OPKO Invests $2M in Cardiac Device Company

OPKO Health, Inc. OPK today announced that it has made an investment in Neovasc Inc. NVC a medical technology company based in Vancouver, Canada. Neovasc is developing unique devices to treat cardiovascular diseases and is also a leading supplier of tissue components for the manufacturers of replacement heart valves. OPKO invested $2 million and received two million Neovasc common shares, and two-year warrants to purchase an additional one million shares for $1.25 a share. OPKO has also entered into an agreement with Neovasc to provide strategic advisory services to Neovasc as it continues to develop and commercialize its novel cardiac devices.